Get the Stockscreener App
24.40
210.83%
16.55
Synaptogenix Inc stock is traded at $24.40, with a volume of 2,066.
It is up +210.83% in the last 24 hours and up +210.83% over the past month.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
See More
Previous Close:
$7.85
Open:
$25.55
24h Volume:
2,066
Relative Volume:
0.00
Market Cap:
$7.07M
Revenue:
-
Net Income/Loss:
$-8.22M
P/E Ratio:
-3.2769
EPS:
-7.4459
Net Cash Flow:
$-4.78M
1W Performance:
+210.83%
1M Performance:
+210.83%
6M Performance:
+877.95%
1Y Performance:
+791.12%
1-Day Range:
$24.40
$25.55
1-Week Range:
$24.40
$25.55
52-Week Range:
$1.84
$25.55
Synaptogenix Inc Stock (SNPX) Company Profile
Name
Synaptogenix Inc
Sector
Industry
Phone
(973) 242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare SNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNPX
Synaptogenix Inc
|
24.40 | 7.07M | 0 | -8.22M | -4.78M | -7.4459 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Synaptogenix Inc Stock (SNPX) Latest News
Is Synaptogenix Inc. stock a dividend growth opportunityWeekly Gains Report & Real-Time Volume Analysis - newser.com
How to build a custom watchlist for Synaptogenix Inc.CPI Data & Accurate Technical Buy Alerts - newser.com
Synaptogenix Inc. stock volume spike explainedJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
Using R and stats models for Synaptogenix Inc. forecastingJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
How rising interest rates impact Synaptogenix Inc. stockWeekly Loss Report & Risk Managed Investment Strategies - newser.com
How to build a dashboard for Synaptogenix Inc. stockPortfolio Value Summary & Consistent Income Trade Recommendations - newser.com
Can Synaptogenix Inc. stock reach $100 price target2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Is Synaptogenix Inc. stock a bargain at current levels2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Why Synaptogenix Inc. is moving todayJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How moving averages guide Synaptogenix Inc. tradingJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
What institutional flow reveals about Synaptogenix Inc.Quarterly Growth Report & Long-Term Capital Growth Ideas - newser.com
Synaptogenix (TAOX) & Its Peers Critical Review - Defense World
[PRE 14A] TAO Synergies Inc. Preliminary Proxy Statement - Stock Titan
How to monitor Synaptogenix Inc. with trend dashboardsShort Setup & Accurate Technical Buy Alerts - newser.com
How Synaptogenix Inc. stock compares to growth peersJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Value Recap: How rising interest rates impact Synaptogenix Inc. stock2025 Market Outlook & Low Risk High Win Rate Picks - fcp.pa.gov.br
Is Synaptogenix Inc. showing signs of accumulationTrade Signal Summary & Long-Term Safe Investment Plans - newser.com
What high frequency data says about Synaptogenix Inc.2025 Earnings Surprises & Technical Buy Zone Confirmations - newser.com
How Synaptogenix Inc. stock valuations compare to rivalsJuly 2025 Reactions & Daily Profit Maximizing Tips - Fundação Cultural do Pará
Core Scientific, Inc.Common Stock (NQ: CORZ - Markets Financial Content
Synaptogenix Inc Stock (SNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):